Waiv, a Paris-based company catalyzing AI precision testing, today announced a $33 million financing round to accelerate the global deployment of its AI precision testing platform. The financing marks ...
Acquired CARD11 Mutation Promotes BCR Independence in Diffuse Large B Cell Lymphoma Despite the well-understood benefits of biomarker and genetic testing in precision medicine, uptake remains low, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results